Bis­pe­cif­ic M&A reach­es As­traZeneca; Count­down for Mer­ck­'s big bid; Biotech buy­out in sav­age times; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Thanks to the short week, we have a lighter edi­tion and few­er sto­ries to re­cap — but the news is no less in­ter­est­ing, and some might just sur­prise you.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.